Cargando…
Development of Real-Time Quantitative Polymerase Chain Reaction Assays to Track Treatment Response in Retinoid Resistant Acute Promyelocytic Leukemia
Molecular detection of minimal residual disease (MRD) has become established to assess remission status and guide therapy in patients with ProMyelocytic Leukemia–RARA+ acute promyelocytic leukemia (APL). However, there are few data on tracking disease response in patients with rarer retinoid resista...
Autores principales: | Jovanovic, Jelena V., Rennie, Kristian, Culligan, Dominic, Peniket, Andrew, Lennard, Anne, Harrison, Justin, Vyas, Paresh, Grimwade, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356041/ https://www.ncbi.nlm.nih.gov/pubmed/22655241 http://dx.doi.org/10.3389/fonc.2011.00035 |
Ejemplares similares
-
Specific Uptake of Retinoids into Human Promyelocytic Leukemia Cells HL‐60 by Retinoid‐specific Binding Protein: Possibly the True Retinoid Receptor
por: Hashimoto, Yuichi, et al.
Publicado: (1988) -
PB1901: NOT ALL VARIANTS OF ACUTE PROMYELOCYTIC LEUKEMIAS ARE RESISTANT TO RETINOIDS.
por: Dandwani, Mehndi, et al.
Publicado: (2023) -
Biphenotypic Acute Leukemia with t(15;17) Lacking Promyelocytic-retinoid Acid Receptor α Rearrangement
por: Saito, Makoto, et al.
Publicado: (2013) -
Molecular Pathogenesis of Secondary Acute Promyelocytic Leukemia
por: Joannides, M., et al.
Publicado: (2011) -
PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation
por: Kamashev, Dmitrii, et al.
Publicado: (2004)